Citations

Mayo Clinic

Showing 10 of 108551 citations.

Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays
Hoofnagle, Andrew N. , Carr, Steven A. , Liu, Tao , Massoni, Sam A., Thomas, Stefani N. , Townsend, R. Reid , Zimmerman, Lisa J. , Boja, Emily S. , Chen, Jing , Crimmins, Daniel L., Davies, Sherri R. , Hiltke, Tara , Ketchum, Karen A. , Kinsinger, Christopher R. , Mesri, Mehdi , Meyer, Matthew R. , Qian, Weijun , Schoenherr, Regine M., Scott, Mitchell G., Shi, Tujin , Whiteley, Gordon , Wrobel, John A. , Wu, Chaochao, Ackermann, Brad, Barnidge, David R. , Bunk, David M. , Clarke, Nigel J. , Fishman, Jordan B., Grant, Russ P., Kushnir, Mark M. , Lowenthal, Mark S. , Neubert, Hendrik , Patterson, Scott D. , Rockwood, Alan L. , Rogers, John , Eyk, Jennifer E. Van , Wong, Steven, Zhang, Shucha, Chan, Daniel W. , Chen, Xian , Liebler, D.C. , Rodland, Karin , Rodriguez, Henry , Paulovich, Amanda G. , Whiteaker, Jeffrey R. , Kuhn, Eric W. , Gao, Yuqian , Aebersold, Ruedi , Grant, Russell P. , Kusebauch, Ulrike , Moritz, Robert L. , Singh, Ravinder J. , Ellis, Matthew J. , Smith, Richard , Zhang, Zhen , Zhang, Hui , Davies, S. J.

Clinical Chemistry | December 30, 2015 | Volume: 62 | Issue: 1 | Pages: 48-69

10.1373/clinchem.2015.250563 | PMID 26719571 Get It

AbstractBACKGROUNDFor many years, basic and clinical researchers have taken advantage of the analytical sensitivity and specificity afforded by mass spectrometry in the measurement of proteins. Clinical laboratories are now beginning to deploy these work flows as well. For assays that use proteolysis to generate peptides for protein quantification and characterization, synthetic stable isotope–labeled internal standard peptides are of central importance. No general recommendations are currently available surrounding the use of peptides in protein mass spectrometric assays.CONTENTThe Clinical Proteomic Tumor Analysis Consortium of the National Cancer Institute has collaborated with clinical laboratorians, peptide manufacturers, metrologists, representatives of the pharmaceutical industry, and other professionals to develop a consensus set of recommendations for peptide procurement, characterization, storage, and handling, as well as approaches to the interpretation of the data generated by mass spectrometric protein assays. Additionally, the importance of carefully characterized reference materials—in particular, peptide standards for the improved concordance of amino acid analysis methods across the industry—is highlighted. The alignment of practices around the use of peptides and the transparency of sample preparation protocols should allow for the harmonization of peptide and protein quantification in research and clinical care.
The Effects of a Polymorphism in the Cytochrome P450 CYP1A2 Gene on Performance Enhancement with Caffeine in Recreational Cyclists
Algrain, Haya , Thomas, Rebecca, Carrillo, Andres E. , Ryan, Emily , Kim, Chul-Ho, Lettan, Robert, Ryan, Edward J., Kim, Chul-Ho

Journal of Caffeine Research | December 30, 2015 | Volume: 6 | Issue: 1 | Pages: 34-39

10.1089/jcr.2015.0029 Get It

Paliperidone Palmitate Associated with Necrotizing Deep Tissue Infection and Sepsis Requiring Surgical Intervention
Leung, Jonathan G. , Kooda, Kirstin , Frazee, Erin N., Nelson, Sarah , Moore, Katherine M. , Kooda, Kirstin J, Frazee, Erin N., Leung, Jonathan G

Case Reports in Psychiatry | December 30, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-3

10.1155/2015/364325 | PMID 26843999 Get It

Long-acting injectable antipsychotics provide the delivery of medication over an extended period of time requiring administration typically only every 2 to 4 weeks. The side effect profile of a long-acting injectable antipsychotic is predictable and similar to the oral formulation. However, injection site reactions may occur with this novel delivery system. The risk of an injection site reaction may be greater with the repeated administration of a lipophilic decanoate formulation and include pain, development of indurations, and fibrosis. Severe complications from injection site reactions have rarely been described in the literature with newer agents. We report the first case of a patient prescribed paliperidone palmitate every 3 weeks that developed severe sepsis requiring vasopressors and intubation due to delayed relayed recognition of a necrotizing infection at an injection site. Clinicians should be alerted to screen for injection site reactions when there is an unknown source infection in a patient receiving a long-acting injectable antipsychotic.
LC-MS/MS for Identifying Patients with CYP24A1 Mutations
Ketha, Hemamalini , Kumar, Rajiv , Singh, Ravinder J. , Kumar, Rajiv

Clinical Chemistry | December 30, 2015 | Volume: 62 | Issue: 1 | Pages: 236-242

10.1373/clinchem.2015.244459 | PMID 26585929 Get It

Abstract BACKGROUND Patients have been described with loss-of-function CYP24A1 (cytochrome P450, family 24, subfamily A, polypeptide 1) mutations that cause a high ratio of 25-hydroxyvitamin D to 24,25-dihydroxyvitamin D [25(OH)D/24,25(OH)2D], increased serum 1,25-dihydroxyvitamin D, and resulting hypercalcemia, hypercalciuria and nephrolithiasis. A 25(OH)D/24,25(OH)2D ratio that can identify patients who are candidates for confirmatory CYP24A1 genetic testing would be valuable. We validated an LC-MS/MS assay for 24,25(OH)2D (D3 and D2) and determined a 25(OH)D/24,25(OH)2D cutoff to identify candidates for confirmatory genetic testing. METHODS After addition of isotope-labeled internal standard, serum samples were extracted by solid-phase extraction, derivatized with 4-phenyl-1,2,4,-triazoline-3,5-dione, and quantified by LC-MS/MS. We measured 25(OH)D/24,25(OH)2D in 91 healthy patients and 34 patients with clinically suspected CYP24A1-mediated hypercalcemia. RESULTS The limits of detection and quantification were 0.03 (0.2) and 0.1 (0.24) nmol/L, respectively, for 24,25(OH)2D3, and 0.1 (0.23) and 0.5 (1.16) nmol/L for 24,25(OH)2D2. Intra- and interassay imprecision was 4%–15% across the analytical measurement range of 0.1–25 ng/mL (0.2–60 nmol/L). No interference was observed with 25(OH)D and 1,25(OH)2D. 25(OH)D/24,25(OH)2D of 7–35 was observed in healthy patients, whereas in 2 patients with CYP24A1 mutations, 25(OH)D/24,25(OH)2D was significantly increased (99–467; P < 0.001). A 25(OH)D/24,25(OH)2D ratio ≥99 identified patients who were candidates for CYP24A1 genetic testing. CONCLUSIONS Increased 25(OH)D/24,25(OH)2D supports the diagnosis of reduced CYP24A1 activity due to mutations in CYP24A1. Measurement of 25(OH)D/24,25(OH)2D should be considered a part of the clinical workup in patients with hypercalcemia of otherwise unknown etiology.
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Presenting as a Primary Central Nervous System Lymphoma
Advani, Pooja , Starr, Jason S. , Swaika, Abhisek, Jiang, Liuyan , Qiu, Yushi, Li, Zhimin , Starr, Jason, Tun, Han W.

Rare Tumors | December 30, 2015 | Volume: 7 | Issue: 4 | Pages: 160-162

10.4081/rt.2015.6084 | PMID 26788280 Get It

Primary central nervous system (PCNSL) lymphoma is an aggressive extranodal non-Hodgkin lymphoma, and most cases are classified as diffuse large B-cell lymphoma (DLBCL) by histology. T-cell/histiocyte-rich large B-cell lymphoma (TCRLBCL) represents a distinct subtype of diffuse large B-cell lymphoma and is characterized by the presence of scattered large neoplastic B-cells in a background of abundant T-cells and histiocytes. This is in contrast to the dense perivascular cuffing of neoplastic B-cells in classic DLBCL. T-cell/histiocyte-rich large B-cell lymphoma should be considered in PCNSL cases in which neoplastic B-cells are sparse and scattered. Immunohistochemistry will help identify the B-cells and surrounding infiltrate rich in Tlymphocytes and histiocytes. Future studies exploring the biology of TCRLBCL and the crosstalk between the neoplastic cells and the surrounding inflammatory infiltrate may provide exciting prospects for future therapies for TCRLBCL.
Excellent Outcome of Immunomodulation or Bruton's Tyrosine Kinase Inhibition in Highly Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
Gupta, Eva , Accurso, Joseph , Sluzevich, Jason C. , Menke, David M. , Sluzevich, Jason, Tun, Han W. , Sluzevich, Jason C

Rare Tumors | December 30, 2015 | Volume: 7 | Issue: 4 | Pages: 164-166

10.4081/rt.2015.6067 | PMID 26788279 Get It

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is a rare diffuse large B-cell lymphoma confined to the skin of the legs. The typical presentation is characterized by solitary or multiple growing plaques, usually confined to one leg. We report a case of PCDLBCL-LT of activated B-cell subtype characterized by multiple local relapses in the legs, initially, and systemic relapses about seven years after the diagnosis. Local relapses were sensitive to radiation therapy. Cutaneous and systemic relapses responded well to immunomodulatory therapy with lenalidomide followed by Bruton's tyrosine kinase inhibition with ibrutinib. Ibrutinib is the only treatment that resulted in long-lasting complete remission. Lenalidomide and especially ibrutinib appear to have a significant activity against this lymphoma and should be incorporated in the treatment of this resistant and aggressive lymphoma. To our knowledge, this is the first case of PCDLBCL-LT reported in the literature exhibiting a complete response to ibrutinib.
Patient-generated health data: a pathway to enhanced long-term cancer survivorship
Petersen, Carolyn , Petersen, Carolyn

Journal of the American Medical Informatics Association | December 30, 2015 | Volume: 23 | Issue: 3 | Pages: 456-461

10.1093/jamia/ocv184 | PMID 26714765 Get It

The growing ability to collect and transmit patient-generated health data, also referred to as people-generated health data and patient-reported outcomes, is creating an opportunity to greatly improve how cancer survivors and their providers manage survivors’ health in the months and years following cancer treatment. Although cancer survivors are at higher risk of chronic health problems and early death as a result of cancer treatment, some experience difficulty identifying and receiving the care they need to optimize their health post-treatment. This article describes the challenges that cancer survivors and their providers face in managing survivors’ care and identifies several ways that using patient-generated health data can improve survivors’ and providers’ ability to manage survivorship care at the individual and population levels.
Bony Versus Soft Tissue Reconstruction for Anterior Shoulder Instability
McLaughlin, Richard J. , Miniaci, Anthony , Jones, Morgan H. , McLaughlin, Richard James, Jones, Morgan H

Orthopaedic Journal of Sports Medicine | December 29, 2015 | Volume: 3 | Issue: 12 | Pages: No page available

10.1177/2325967115618161 | PMID 26779552 Get It

Background: One complication of anteroinferior glenohumeral shoulder dislocation is a critical bone defect that requires surgical repair to prevent recurrent instability. However, controversy exists regarding the surgical management because both open and arthroscopic surgeries have respective advantages and disadvantages. Moreover, it is difficult to determine the patient’s preferred treatment, as factors that influence treatment choice include recurrence rates, morbidity of the procedures, and patient preferences. Hypothesis: Patients who have a higher probability of recurrent instability after arthroscopic surgery will select open surgery whereas patients with a lower probability of recurrent instability after arthroscopic surgery will favor arthroscopy. Study Design: Economic and decision analysis; Level of evidence, 2. Methods: A decision tree was constructed to model each hypothetical outcome after open or arthroscopic surgery for glenohumeral instability in patients with bone defects. A literature review was performed to determine the probability of occurrence for each node while utility values for each outcome were obtained via patient-administered surveys given to 50 patients without prior history of shoulder injury or dislocation. Fold-back analysis was then performed to show the optimal treatment strategy. Finally, sensitivity analysis established the thresholds at which open treatment becomes the optimal treatment. Results: The ultimate expected value—the objective evaluation of all potential outcomes after choosing either open or arthroscopic surgery—was found to be greater for arthroscopic surgery than for open surgery (87.17 vs 81.64), indicating it to be the preferred treatment. Results of sensitivity analysis indicated that open surgery becomes the preferred treatment when probability of recurrence after arthroscopic treatment is ≥23.8%, although varying the utility, defined as an aggregate patient preference for a particular outcome, has no effect on the model. When the rate of no complication after open surgery is 97.6%, open surgery becomes the patient’s preferred treatment. Conclusion: Arthroscopic surgery is an acceptable treatment if recurrent instability occurs consistently at ≤23.8%. This has important implications given the technical difficulty of successfully performing arthroscopic fixation to resolve recurrent anteroinferior glenohumeral dislocations associated with critical osseous defects. However, due to a lack of clinical outcomes studies, more research is needed to better predict the optimal operative treatment.
Venous thromboembolism after radical cystectomy: Experience with screening ultrasonography
Murray, Katie M., Parker, William P. , Stephany, Heidi A., Redger, Kirk, Mirza, Moben, Lopez‐Corona, Ernesto, Holzbeierlein, Jeffrey M., Lee, Eugene K. , Parker, William , Murray, Katie M.

Arab Journal of Urology | December 29, 2015 | Volume: 14 | Issue: 1 | Pages: 37-43

10.1016/j.aju.2015.11.002 | PMID 26966592 Get It

Incidence and risk factors of acute kidney injury following transcatheter aortic valve replacement
Cheungpasitporn, Wisit , Srivali, Narat , Kittanamongkolchai, Wonngarm , Greason, Kevin L. , Thongprayoon, Charat , Kashani, Kianoush , Cheungpasitporn, Wisit , Srivali, Narat

Nephrology | December 29, 2015 | Volume: 21 | Issue: 12 | Pages: 1041-1046

10.1111/nep.12704 | PMID 26714182 Get It

AbstractAimThis study aimed to determine the incidence and risk factors of acute kidney injury (AKI) following transcatheter aortic valve replacement (TAVR).MethodsWe included all adult patients undergoing TAVR for aortic stenosis from 1 January 2008 to 30 June 2014 at a tertiary referral hospital. AKI was defined based on Kidney Disease: Improving Global Outcomes criteria. We performed a multivariate logistic regression to identify factors associated with post‐procedural AKI occurrence.ResultsThree hundred eighty‐six patients met the inclusion criteria, of which 106 (28%) developed AKI. In multivariate analysis, AKI development was independently associated with a transapical approach (odds ratio (OR), 2.81; 95% confidence interval (CI), 1.72–4.65 compared with transfemoral approach) and the need for an intra‐aortic balloon pump (OR, 9.11; 95% CI, 1.77–68.29). Higher baseline renal function (OR, 0.78 per 10 mL/min per 1.73 m2 increment in glomerular filtration rate; 95% CI, 0.68–0.87) was significantly associated with a decreased risk of AKI. After adjustment for the Society of Thoracic Surgeons' risk score, post‐procedural AKI development remained significantly associated with an increased in‐hospital (OR, 4.74; 95% CI, 1.39–18.48) and 6‐month mortality (OR, 4.66; 95% CI, 2.32–9.63).ConclusionIn a cohort of patients undergoing TAVR for aortic stenosis, AKI commonly occurred and was significantly associated with increased mortality. Baseline renal function, procedure approach and the need for circulatory support were important predictive factors for post‐procedural AKI occurrence.